2.3. Definition of Confounders and Noncommunicable Diseases

HS Hironobu Sunadome
KM Kimihiko Murase
YT Yasuharu Tabara
TM Takeshi Matsumoto
TM Takuma Minami
OK Osamu Kanai
TN Tadao Nagasaki
NT Naomi Takahashi
SH Satoshi Hamada
KT Kiminobu Tanizawa
JT Jumpei Togawa
SU Sayaka Uiji
TW Tomoko Wakamura
NK Naoko Komenami
KS Kazuya Setoh
TK Takahisa Kawaguchi
SM Satoshi Morita
YT Yoshimitsu Takahashi
TN Takeo Nakayama
TH Toyohiro Hirai
SS Susumu Sato
FM Fumihiko Matsuda
KC Kazuo Chin
ask Ask a question
Favorite

Body mass index (BMI) was assessed, and obesity was defined as a BMI ≥ 25 kg/m2. Hypertension was considered present if subjects showed office systolic blood pressure (sBP) ≥ 140 mmHg or diastolic blood pressure (dBP) ≥ 90 mmHg in a seated position after a few minutes of rest or had taken antihypertensive agents. DM was considered present if subjects showed glycated hemoglobin (HbA1c) > 6.5% or had taken oral antihyperglycemic agents and/or insulin. The assessment of dyslipidemia (DL) was performed on participants in a fasting state (≥10 h). DL was considered present if subjects showed low-density lipoprotein (LDL) ≥ 140 mg/dL, high-density lipoprotein (HDL) < 40 mg/dL, triglycerides (TG) ≥ 150 mg/dL, or had antihyperlipidemic agents. MetS was considered present if subjects had waist circumference ≥ 85 cm in males or ≥90 cm in females and had two or more of the following traits: (1) sBP/dBP ≥ 130/85 mmHg or having taken antihypertensive drugs, (2) fasting glucose ≥ 100 or having received treatment for DM, and (3) fasting HDL ≤ 40 mg/dL, TG ≥ 150 mg/dL or having received treatment for DL.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A